Sponsor Pipeline

Chiesi Farmaceutici S.p.A. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
19
Active Trials
15
Recruiting
7
Phase 3
3
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-01 NCT07666490
BETRI-Prospective: Asthma Control in Single Inhaler ICS/LABA/LAMA (87/5/9 pMDI [BDP/FF/GB…
Recruitment opened
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-08-04 NCT07744386 A Study in Healthy Male Participants to Compare How CHF10196 Affects How the Body Absorbs… Phase 1 Not Yet Recruiting
Active Trials by Phase
Phase 4
1
Phase 3
5
Phase 2/3
2
Phase 2
2
Phase 1/2
1
Phase 1
3
Not specified
5
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT07666490 BETRI-Prospective: Asthma Control in Single Inhaler ICS/LABA/LAMA (87/5/9 pMDI [BDP/FF/GB… Asthma Recruiting
Phase 3
NCT06917690 A Study to Learn About the Safety and Efficacy of the Drug Oleogel-S10 in Japanese… Epidermolysis Bullosa Recruiting
NCT07546981 Efficacy and Safety of CHF 5993 100/6/12.5 μg HFA-152a pMDI in Patients With Asthma… Asthma Recruiting
NCT06679270 Open-label Extension Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy Familial Partial Lipodystrophy Recruiting
NCT05164341 Study to Evaluate the Safety and Efficacy of Daily Subcutaneous Metreleptin Treatment in… Partial Lipodystrophy Active, Not Recruiting
NCT07577804 A Study to Evaluate the Efficacy and Safety of CHF10196 Tablets (Florensocatib) Compared… Bronchiectasis Not Yet Recruiting
Phase 2/3
NCT05710692 Study to Evaluate the Safety, PK, PD, and Efficacy of PRX-102 in Japanese Patients With… Fabry Disease Recruiting
NCT06328608 A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and… Fabry Disease Recruiting
Phase 2
NCT07301736 Therapeutic Equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a in Subjects With Mild to… Asthma Recruiting
NCT07516951 A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants… Idiopathic Pulmonary Fibrosis Recruiting
Phase 1/2
NCT06166056 A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Inhaled CHF6333… Bronchiectasis Recruiting
Phase 1
NCT07163182 Evaluation of Safety, Side Effects and How the Drug CHF6467 Administered Via Intranasal… Healthy Volunteers Recruiting
NCT07683793 A Study to Compare How CHF10196 (Florensocatib) is Absorbed Into the Blood When Given… Healthy Volunteers Not Yet Recruiting
NCT07744386 A Study in Healthy Male Participants to Compare How CHF10196 Affects How the Body Absorbs… Healthy Male Volunteers Not Yet Recruiting
Not specified
NCT05652439 PASS to Assess Cardiovascular and Cerebrovascular Events in COPD Patients Initiating… Chronic Obstructive Pulmonary Disease Recruiting
NCT06184503 Analysis of Velmanase Alfa (Lamzede®)'s Effects in the Body of Children With… Alpha-Mannosidosis Recruiting
NCT06663358 A Multi-Country Observational Study of Safety and Effectiveness of Elfabrio® in Fabry… Fabry Disease Recruiting
NCT06941025 Maternal and Postnatal Outcomes Study (MOS): A Global Observational Registry Assessing… Fabry Disease Recruiting
NCT02325674 MEASuRE: Metreleptin Effectiveness And Safety Registry Generalised Lipodystrophy Recruiting
Disease Areas
Get alerts when Chiesi Farmaceutici S.p.A.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free